Pharvaris N.V. (PHVS), a notable player in the biotechnology sector, is capturing investor attention with its promising focus on rare disease therapies. Headquartered in Zug, Switzerland,..
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a healthcare innovator making significant strides in the drug manufacturing sector, particularly within the specialty and generic drug industry. Headquartered..
Simulations Plus, Inc. (NASDAQ: SLP) is carving a niche within the healthcare sector, particularly in the health information services industry. The company’s software solutions for drug..
SI-BONE, Inc. (NASDAQ: SIBN) stands out as a promising player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $845.26..
Cronos Group Inc. (NASDAQ: CRON), a key player in the global cannabinoid market, continues to capture the attention of investors with its unique position in the..
CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostic solutions for transplant patients, has recently caught the attention of investors with..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a notable player in the healthcare sector, specifically in biotechnology, has captured the attention of investors with its significant potential upside...
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing attention in the biotech sector with its innovative approach to tackling unmet medical needs in cancer treatment. With a..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) is capturing attention in the biotechnology sector with its innovative approach to gene editing. Headquartered in Cambridge, Massachusetts, Intellia is a..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is attracting significant interest from investors, particularly given its compelling potential upside of 119.86%. This biopharmaceutical company, headquartered in Cambridge, Massachusetts,..
Ardelyx, Inc. (NASDAQ: ARDX) has emerged as a notable player in the biotechnology sector, drawing investor attention with its promising drug portfolio and significant potential upside...
CeriBell, Inc. (NASDAQ: CBLL), a cutting-edge player in the healthcare sector, is capturing attention with its innovative medical devices and a notable potential upside of 46.15%...
CorMedix Inc. (NASDAQ: CRMD), a promising player in the biotechnology sector, is capturing investor attention with its impressive growth metrics and significant potential upside. As a..
Fulgent Genetics, Inc. (FLGT), a prominent player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with a notable potential upside of..
Embecta Corp. (NASDAQ: EMBC) stands at the intersection of innovation and healthcare, offering compelling opportunities for investors focused on the medical instruments and supplies sector. With..
Niagen Bioscience, Inc. (NASDAQ: NAGE), a dynamic player in the biotechnology sector, is grabbing the attention of investors with its remarkable potential upside and robust growth..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a key player in the biotechnology sector, is generating notable interest among investors due to its promising drug pipeline and substantial..
Nurix Therapeutics, Inc. (NRIX) is making waves in the biotechnology sector, with promising developments in its clinical-stage pipeline and strong analyst support suggesting a notable upside..
Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its ambitious focus on innovative treatments for inflammatory bowel disease..
